| Comparison of Two Basal Insulin Therapies for Patients With Type 1 Diabetes (NCT00487240) | Eli Lilly and Company | 2007-06-01 |
| Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy (NCT00503685) | Eli Lilly and Company | 2007-06-01 |
| A Phase 2 Study With Enzastaurin Plus Chemotherapy or Placebo Plus Chemotherapy for Prostate Cancer Patients (NCT00466440) | Eli Lilly and Company | 2007-06-01 |
| A First-in-Human Study of LY2409021 in Healthy Participants and Participants With Type 2 Diabetes (NCT01606371) | Eli Lilly and Company | 2007-05-01 |
| A Study of Enzastaurin in Patients With Leukemia (NCT00452257) | Eli Lilly and Company | 2007-05-01 |
| A Study of Pemetrexed Plus Carboplatin, or Pemetrexed Plus Cisplatin With Radiation Therapy Followed by Pemetrexed in Patients With Inoperable Non-Small-Cell Lung Cancer (NCT00482014) | Eli Lilly and Company | 2007-05-01 |
| A Study of Enzastaurin in Participants With Follicular Lymphoma (NCT00475644) | Eli Lilly and Company | 2007-05-01 |
| A Study of Enzastaurin and Erlotinib in Participants With Solid Tumors and Lung Cancer (NCT00452413) | Eli Lilly and Company | 2007-05-01 |
| A Study of Participants With Lymphoma Who Take R-CHOP and Enzastaurin Compared to Participants Who Take R-CHOP Only (NCT00451178) | Eli Lilly and Company | 2007-05-01 |
| Enzastaurin Plus Fulvestrant vs. Placebo Plus Fulvestrant in Breast Cancer (NCT00451555) | Eli Lilly and Company | 2007-04-11 |
| An Observational Study of Olanzapine Coated and Orodispersible Tablets Effectiveness in Schizophrenic and Bipolar Outpatients. (NCT00510211) | Eli Lilly and Company | 2007-04-01 |
| A Study for Patients With Type 1 Diabetes Mellitus (NCT00447213) | Eli Lilly and Company | 2007-04-01 |
| A Study for Patients With Attention-Deficit/Hyperactivity Disorder Treated With Atomoxetine (NCT00471354) | Eli Lilly and Company | 2007-04-01 |
| A Study Comparing the Effect of Atomoxetine Versus Other Standard Care Therapy on the Long Term Functioning in Attention-Deficit/Hyperactivity Disorder (ADHD) Children and Adolescents (NCT00447278) | Eli Lilly and Company | 2007-03-01 |
| Enzastaurin in Combination of Capecitabine to Treat Breast Cancer (NCT00437294) | Eli Lilly and Company | 2007-03-01 |
| A Study of Irinotecan Plus Cetuximab With or Without Enzastaurin in Participants With Colorectal Cancer (NCT00437268) | Eli Lilly and Company | 2007-03-01 |
| The Effect on Blood Cells, Known as Platelets, Using Prasugrel vs Clopidogrel in Patients With the Heart Problem Acute Coronary Syndrome (ACS) (NCT00385944) | Eli Lilly and Company | 2007-03-01 |
| Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease (NCT00437125) | Eli Lilly and Company | 2007-03-01 |
| Study of Pemetrexed Versus Pemetrexed Plus Erlotinib as Treatment of Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (NCT00447057) | Eli Lilly and Company | 2007-03-01 |
| A Study Evaluating Duloxetine in Patients Hospitalized for Severe Depression (NCT00422162) | Eli Lilly and Company | 2007-02-01 |
| Chemotherapy for Participants With Lymphoma (NCT00436280) | Eli Lilly and Company | 2007-02-01 |
| An Observational Study of the Ethnic Impact of Patients Undergoing Second (2nd) Line Treatment for Non-Small Cell Lung Cancer Using Pemetrexed (NCT00497770) | Eli Lilly and Company | 2007-02-01 |
| A Study for Patients With Multiple Sclerosis (NCT00870155) | Eli Lilly and Company | 2007-02-01 |
| Duloxetine vs. Placebo in the Treatment of Osteoarthritis Knee Pain (NCT00433290) | Eli Lilly and Company | 2007-02-01 |
| A Study of Chemotherapy Treatment for Patients With Ovarian Cancer (NCT00428610) | Eli Lilly and Company | 2007-02-01 |
| Pemetrexed and Gemcitabine Every 14 Days Versus Every 21 Days in Advanced Non Small Cell Lung Cancer (NCT00383331) | Eli Lilly and Company | 2007-02-01 |
| Chemotherapy for Patients With Non-Small Cell Lung Cancer Who Are Non-Smokers (NCT00409006) | Eli Lilly and Company | 2007-02-01 |
| Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes (NCT00437112) | Eli Lilly and Company | 2007-02-01 |
| A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy (NCT00447421) | Eli Lilly and Company | 2007-02-01 |
| Safety and Tolerability of IC83/LY2603618 Administered After Pemetrexed 500 mg/m2 Every 21 Days in Patients With Cancer (NCT00415636) | Eli Lilly and Company | 2007-01-01 |
| Phase 3 Clinical Trial of Teriparatide in Japan (NCT00433160) | Eli Lilly and Company | 2007-01-01 |
| A Phase I Trial of Enzastaurin (LY317615) in Combination With Carboplatin in Adults With Recurrent Gliomas (NCT01445119) | Eli Lilly and Company | 2007-01-01 |
| Duloxetine Versus Placebo in Chronic Low Back Pain (NCT00424593) | Eli Lilly and Company | 2007-01-01 |
| Evaluation of Enzastaurin in the Treatment of Persistent or Recurrent Ovarian or Primary Peritoneal Cancer (NCT00420381) | Eli Lilly and Company | 2007-01-01 |
| A Study for Patients With Diabetes Mellitus (IOPA) (NCT00420095) | Eli Lilly and Company | 2007-01-01 |
| Phase 2 Trial of Enzastaurin in Prostate Cancer in Participants Who Have Had Hormonal and Chemotherapy (NCT00428714) | Eli Lilly and Company | 2007-01-01 |
| A Study for Patients With Head and Neck Cancer (NCT00415194) | Eli Lilly and Company | 2006-12-01 |
| Pemetrexed Plus Cisplatin as First-Line Treatment in Stage IV or Recurrence of Gastric Cancer (NCT00415168) | Eli Lilly and Company | 2006-12-01 |
| Study of Enzastaurin Versus Placebo in the Treatment of Patients With Brain Metastases of Lung Cancer, After Whole Brain Radiation Therapy (NCT00415363) | Eli Lilly and Company | 2006-12-01 |
| A Study for Participants With Major Depression (NCT00420004) | Eli Lilly and Company | 2006-12-01 |
| Study of Pemetrexed in Mesothelioma and Lung Cancer Patients With Fluid Around the Lungs or Abdomen (NCT00316225) | Eli Lilly and Company | 2006-12-01 |
| Duloxetine Versus Placebo in the Treatment of Patients With Diabetic Peripheral Neuropathic Pain in China (NCT00408993) | Eli Lilly and Company | 2006-12-01 |
| A Study of Cetuximab and Bevacizumab in Combination With Paclitaxel and Carboplatin in Stage IIIb/IV NSCLC (NCT00343291) | Eli Lilly and Company | 2006-12-01 |
| Duloxetine Versus Placebo in Chronic Low Back Pain (NCT00408876) | Eli Lilly and Company | 2006-12-01 |
| A Study for Patients With Osteoporosis (NCT00414973) | Eli Lilly and Company | 2006-12-01 |
| A Comparison of Olanzapine in Combination With a Mood Stabilizer vs Mood Stabilizer Alone, in Mixed Bipolar Patients (NCT00402324) | Eli Lilly and Company | 2006-12-01 |
| Study of IMC-3G3 in Patients With Tumors That Are Not Responding to Standard Therapies or No Therapy is Available (NCT00768391) | Eli Lilly and Company | 2006-12-01 |
| A Study for Patients With Relapsing Remitting Multiple Sclerosis (NCT00869986) | Eli Lilly and Company | 2006-11-01 |
| Evaluate Protein C Levels in Severe Sepsis Patients on Drotrecogin Alfa (Activated) (NCT00386425) | Eli Lilly and Company | 2006-11-01 |
| A Placebo-Controlled Adaptive Treatment Assignment Study of Intravenous COL-144 in the Acute Treatment of Migraine (NCT00384774) | Eli Lilly and Company | 2006-11-01 |
| Enzastaurin For Breast Cancer Patients Who Previously Received an Anthracycline and a Taxane Chemotherapy (NCT00386087) | Eli Lilly and Company | 2006-11-01 |
| Chemotherapy With Pemetrexed in Combination With Platinum for Advanced Non-Small Cell Lung Cancer (NSCLC) (NCT00402051) | Eli Lilly and Company | 2006-11-01 |
| Comparison of Atomoxetine Versus Placebo in Children and Adolescents With ADHD and Comorbid ODD in Germany (NCT00406354) | Eli Lilly and Company | 2006-11-01 |
| Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill") (NCT00391118) | Eli Lilly and Company | 2006-11-01 |
| A Study of Tasisulam in Treating Participants With Malignant Melanoma (NCT00383292) | Eli Lilly and Company | 2006-11-01 |
| Assessment of Safety and Efficacy of Therapy for the Prevention of Weight Gain Associated With Olanzapine (NCT00401973) | Eli Lilly and Company | 2006-11-01 |
| Chemotherapy for Patients With Non-Small Cell Lung Cancer (NCT00380718) | Eli Lilly and Company | 2006-11-01 |
| Duloxetine Versus Placebo for Osteoarthritis Knee Pain (NCT00408421) | Eli Lilly and Company | 2006-11-01 |
| A Study Comparing the Efficacy and Safety of Duloxetine and Placebo for the Treatment of Depression in Elderly Patients (NCT00406848) | Eli Lilly and Company | 2006-11-01 |
| Evaluation of the Effects of Duloxetine on Norepinephrine (NCT00414323) | Eli Lilly and Company | 2006-11-01 |
| Tadalafil Taken Daily Compared to Placebo on Improvement of Getting and Maintaining an Erection and Sexual Quality of Life (NCT00422734) | Eli Lilly and Company | 2006-11-01 |
| Enzastaurin and Bevacizumab in Treating Patients With Locally Advanced or Metastatic Cancer (NCT00550927) | Eli Lilly and Company | 2006-11-01 |
| Safety Confirmation Study of Pemetrexed Plus Cisplatin in Patients With Malignant Pleural Mesothelioma (NCT00386815) | Eli Lilly and Company | 2006-10-01 |
| Atomoxetine Versus Placebo for Symptoms of Attention-Deficit/Hyperactivity Disorder (ADHD) in Children and Adolescents With Autism Spectrum Disorder (NCT00380692) | Eli Lilly and Company | 2006-10-01 |
| Effects of Tadalafil Once a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (NCT00386009) | Eli Lilly and Company | 2006-10-01 |
| Chemotherapy for Patients With Non-Small Cell Lung Cancer (NSCLC) (NCT00391274) | Eli Lilly and Company | 2006-10-01 |
| Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus (NCT00391209) | Eli Lilly and Company | 2006-10-01 |
| Lispro Mid Mixture (MM) Intensive Mixture Therapy With Progressive Dose-Titration of Lispro Low Mixture (LM) or Biphasic Insulin Aspart 30/70 (S019) (NCT00393705) | Eli Lilly and Company | 2006-10-01 |
| Study Comparing Arzoxifene With Raloxifene in Women After Menopause With Osteoporosis (NCT00383422) | Eli Lilly and Company | 2006-10-01 |
| An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain (NCT00385671) | Eli Lilly and Company | 2006-09-01 |
| Randomized Phase 2 Study With Gemcitabine Alone and Combination Therapy for Patients With Advanced Biliary Tract Cancer (NCT00380588) | Eli Lilly and Company | 2006-09-01 |
| Chemotherapy Treatment in Re-occurring Non Small Cell Lung Cancer (NSCLC) After Previous Chemotherapy and Surgical Removal of the NSCLC Tumor (NCT00356525) | Eli Lilly and Company | 2006-09-01 |
| A Study in People With Mild Hypertension (NCT00374855) | Eli Lilly and Company | 2006-09-01 |
| Phase 1/2 Study of Enzastaurin in Newly Diagnosed Glioblastoma Multiforme (GBM) and Gliosarcoma (GS) Patients (NCT00402116) | Eli Lilly and Company | 2006-09-01 |
| A Trial for Patients With Advanced/Recurrent Endometrial Cancer (NCT00377520) | Eli Lilly and Company | 2006-09-01 |
| Study of LY573636-Sodium in Patients With Metastatic Non-Small Cell Lung Cancer (NCT00363766) | Eli Lilly and Company | 2006-09-01 |
| Dosage Schedule Study of Pemetrexed Monochemotherapy for Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT00370292) | Eli Lilly and Company | 2006-09-01 |
| Trial in Subjects Undergoing Cardiac Catheterization With Planned Percutaneous Coronary Intervention With Stenting (NCT00357968) | Eli Lilly and Company | 2006-08-01 |
| Study of Tadalafil Once-a Day for 12 Weeks in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (NCT00384930) | Eli Lilly and Company | 2006-08-01 |
| Pemetrexed Plus Cisplatin Bi-Weekly, in Patients With Urothelial Cancer (Metastatic, Locally Advanced or Non-Resectable) (NCT00374868) | Eli Lilly and Company | 2006-08-01 |
| Pemetrexed/Carboplatin Non-Small Cell Lung Cancer (NSCLC) Elderly Patients (NCT00350792) | Eli Lilly and Company | 2006-08-01 |
| Evaluate the Efficacy and Safety of Insulin in Patients With Type 2 Diabetes (NCT00355849) | Eli Lilly and Company | 2006-08-01 |
| Comparison of Two Approaches to Insulin Therapy in Patients With Type 2 Diabetes (IOOX) (NCT00377858) | Eli Lilly and Company | 2006-08-01 |
| Evaluate the Efficacy of Insulin Patients With Type 1 Diabetes (NCT00356109) | Eli Lilly and Company | 2006-08-01 |
| Study of Pemetrexed and Carboplatin Compared With Etoposide Carboplatin to Treat Extensive-Stage Small Cell Lung Cancer (NCT00363415) | Eli Lilly and Company | 2006-08-01 |
| Safety Study of IMC-18F1,to Treat Advanced Solid Tumors in Subjects That no Longer Respond to Standard Therapy (NCT00782002) | Eli Lilly and Company | 2006-07-01 |
| A Study of Healthy Subjects to Assess the Effect of LY450139 on Amyloid Beta Peptide Production Rate and or Dose Response. (NCT00765115) | Eli Lilly and Company | 2006-07-01 |
| A Trial for Patients With Gestational Trophoblastic Disease (NCT00190918) | Eli Lilly and Company | 2006-07-01 |
| Effect of Prasugrel on Platelets After One Week in Patients Already Taking Clopidogrel After a Cardiac Event (NCT00356135) | Eli Lilly and Company | 2006-07-01 |
| A Study of Pemetrexed and Folic Acid Given Before Surgery (Neoadjuvant Treatment) to Patients With Rectal Cancer. (NCT00330915) | Eli Lilly and Company | 2006-06-01 |
| Effect of Teriparatide Compared to Risedronate on Back Pain in Women With a Spine Fracture Caused by Osteoporosis (NCT00343252) | Eli Lilly and Company | 2006-06-01 |
| PRELUDE:Study to Investigate the Prevention of Relapse in Lymphoma Using Daily Enzastaurin (NCT00332202) | Eli Lilly and Company | 2006-06-01 |
| Combination Chemotherapy of Gemcitabine and Paclitaxel for Metastatic Breast Cancer (NCT00334802) | Eli Lilly and Company | 2006-06-01 |
| Somatropin + Leuprorelin vs Somatropin Alone in Pubertal Children With Idiopathic Short Stature (NCT00355030) | Eli Lilly and Company | 2006-06-01 |
| Pemetrexed-Carboplatin and Gemcitabine-Vinorelbine in Advanced Breast Cancer (NCT00325234) | Eli Lilly and Company | 2006-06-01 |
| A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes (NCT00330473) | Eli Lilly and Company | 2006-06-01 |
| Patient's Preference Between Conventional Oral Olanzapine Tablet vs Olanzapine Orodispersible Tablet (NCT00324051) | Eli Lilly and Company | 2006-05-01 |
| A Trial of Paclitaxel and Bevacizumab vs. Gemcitabine, Paclitaxel, and Bevacizumab in Advanced Breast Cancer (NCT00320541) | Eli Lilly and Company | 2006-05-01 |
| Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers (NCT00329082) | Eli Lilly and Company | 2006-05-01 |
| Cetuximab and Bevacizumab With or Without Gemcitabine to Treat Metastatic Pancreatic Cancer (NCT00326911) | Eli Lilly and Company | 2006-05-01 |